Singapore's Temasek Joins In $11 Billion Buyout Bid For Life Technologies
This article was originally published in PharmAsia News
Executive Summary
Singapore's Temasek Holdings reportedly has joined with three international investment groups to offer $11 billion to acquire Life Technologies, maker of genetic-sequencing devices.